Dupilumab in atopic dermatitis, a protocol forSARS-COV-2-infected patients

被引:8
作者
Ordonez-Rubiano, Maria Fernanda [1 ,2 ]
Campo, Isabela [2 ]
Casas, Mirian [1 ]
机构
[1] Cayre Clin Ctr, Dept Dermatol, Atop Dermatitis Clin, Bogota, Colombia
[2] Mil Cent Hosp, Dept Internal Med, Div Dermatol, TV 3C 49-02, Bogota, DC, Colombia
关键词
D O I
10.1111/dth.14172
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页数:2
相关论文
共 8 条
[1]   SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab [J].
Caroppo, F. ;
Biolo, G. ;
Belloni Fortina, A. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (08) :E368-E368
[2]   Evidence-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19 [J].
Galimberti, Fabrizio ;
McBride, Jeffrey ;
Cronin, Megan ;
Li, Yumeng ;
Fox, Joshua ;
Abrouk, Michael ;
Herbst, Alexander ;
Kirsner, Robert S. .
CLINICS IN DERMATOLOGY, 2020, 38 (06) :775-780
[3]   Safety of dupilumab in atopic patients during COVID-19 outbreak [J].
Napolitano, Maddalena ;
Patruno, Cataldo ;
Ruggiero, Angelo ;
Nocerino, Mariateresa ;
Fabbrocini, Gabriella .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (01) :600-601
[4]   Dupilumab and COVID-19: What should we expect? [J].
Patruno, Cataldo ;
Stingeni, Luca ;
Fabbrocini, Gabriella ;
Hansel, Katharina ;
Napolitano, Maddalena .
DERMATOLOGIC THERAPY, 2020, 33 (04)
[5]   Considerations for safety in the use of systemic medications for psoriasis and atopic dermatitis during theCOVID-19 pandemic [J].
Ricardo, Jose W. ;
Lipner, Shari R. .
DERMATOLOGIC THERAPY, 2020, 33 (05)
[6]   Management of adult patients with severe atopic dermatitis treated with dupilumab duringCOVID-19 pandemic: A single-center real-life experience [J].
Rossi, Mariateresa ;
Rovati, Chiara ;
Arisi, Mariachiara ;
Soglia, Simone ;
Calzavara-Pinton, Piergiacomo .
DERMATOLOGIC THERAPY, 2020, 33 (04)
[7]   Severe Adult Atopic Dermatitis: Clinical Challenges [J].
Russo, Filomena ;
Flori, Maria Laura ;
Gola, Massimo ;
Milanesi, Nicola .
DERMATITIS, 2020, 31 (04) :E48-E49
[8]   European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis [J].
Wollenberg, A. ;
Flohr, C. ;
Simon, D. ;
Cork, M. J. ;
Thyssen, J. P. ;
Bieber, T. ;
de Bruin-Weller, M. S. ;
Weidinger, S. ;
Deleuran, M. ;
Taieb, A. ;
Paul, C. ;
Trzeciak, M. ;
Werfel, T. ;
Seneschal, J. ;
Barbarot, S. ;
Darsow, U. ;
Torrelo, A. ;
Stalder, J. -F. ;
Svensson, A. ;
Hijnen, D. ;
Gelmetti, C. ;
Szalai, Z. ;
Gieler, U. ;
De Raeve, L. ;
Kunz, B. ;
Spuls, P. ;
von Kobyletzki, L. B. ;
Foelster-Holst, R. ;
Chernyshov, P. V. ;
Christen-Zaech, S. ;
Heratizadeh, A. ;
Ring, J. ;
Vestergaard, C. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (06) :E241-E242